BRCA2 and pancreatic neoplasm: The simulated populations varied from general populations, to high‐risk groups (such as BRCA2 gene mutation carriers or kindreds of familial pancreatic cancer patients [FPC] or individuals with pancreatic cystic lesions), to PC patients.